IP Library Granted Patent US 9,610,297
Granted Patent B2
US 9,610,297 · App. 14/808,425 · Granted Apr 4, 2017

Stabilization of vitamin B

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,610,297
App. No.
14/808,425
Granted
Apr 4, 2017
Kind
B2
Abstract

The invention relates to preparations comprising vitamin B 12 and a butanol, and to the use of butanol for stabilizing vitamins.

Claims (23)

1. A photostable vitamin B 12 formulation comprising:

0.001 to 0.01% m/V vitamin B 12 ;

butaphosphan;

0.5 to 7% n-butanol m/V; and

water,

wherein the pH of the formulation is from about 4 to about 7.

2. The formulation of claim 1 comprising from 1 to 5% m/V n-butanol.

3. The formulation of claim 1 comprising from 2 to 4% m/V n-butanol.

4. The formulation of claim 1 comprising from 0.005 to 0.01% m/V vitamin B 12 .

5. The formulation of claim 1 comprising from 1 to 30% m/V butaphosphan.

6. The formulation of claim 1 comprising from 5 to 20% m/V butaphosphan.

7. The formulation of claim 2 comprising from 5 to 20% m/V butaphosphan.

8. The formulation of claim 1 , wherein the pH of the formulation is 5.6±0.2.

9. The formulation of claim 7 , wherein the pH of the formulation is 5.6±0.2.

10. The formulation of claim 1 , wherein the vitamin B 12 is cyanocobalamin.

11. The formulation of claim 7 , wherein the vitamin B 12 is cyanocobalamin.

12. The formulation of claim 1 further comprising a base.

13. The formulation of claim 11 further comprising a base.

14. The formulation of claim 13 , wherein the base comprises sodium hydroxide.

15. The formulation of claim 1 , wherein water constitutes over 75% m/V of the formulation.

16. The formulation of claim 11 , wherein water constitutes over 75% m/V of the formulation.

17. The formulation of claim 1 further comprising a cosolvent.

18. The formulation of claim 1 further comprising an antioxidant, wetting agent, or combinations thereof.

Assignments (5)
CHANGE OF NAME Recorded Feb 8, 2024
From: BAYER ANIMAL HEALTH GMBH
To: ELANCO ANIMAL HEALTH GMBH
Reel/Frame 066525/0898 →
NUNC PRO TUNC ASSIGNMENT Recorded Feb 7, 2024
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER ANIMAL HEALTH GMBH
Reel/Frame 066401/0955 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2016
From: HEEP, IRIS, DR.; TATERRA, HANS-ROLF
To: BAYER HEALTHCARE AG
Reel/Frame 038746/0726 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2016
From: BAYER HEALTHCARE AG
To: BAYER ANIMAL HEALTH GMBH
Reel/Frame 038746/0811 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2016
From: BAYER ANIMAL HEALTH GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 038746/0904 →